88
Views
25
CrossRef citations to date
0
Altmetric
Original

The Anticonvulsant Zonisamide Reduces Ethanol Self-Administration by Risky Drinkers

, M.D., , Ph.D., , M.D., , Ph.D., , B.A., , B.A., , M.D., , B.A., , B.S.N., , Ph.D. & , M.D. show all
Pages 316-319 | Published online: 15 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Lara A. Ray, Spencer Bujarski, Erica Grodin, Emily Hartwell, ReJoyce Green, Alexandra Venegas, Aaron C. Lim, Artha Gillis & Karen Miotto. (2019) State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American Journal of Drug and Alcohol Abuse 45:2, pages 124-140.
Read now
Raye Z. Litten, Bonnie B. Wilford, Daniel E. Falk, Megan L. Ryan & Joanne B. Fertig. (2016) Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. Substance Abuse 37:2, pages 286-298.
Read now
Ewa Zwierzyńska, Agata Krupa & Bogusława Pietrzak. (2015) A pharmaco-EEG study of the interaction between ethanol and retigabine in rabbits. The American Journal of Drug and Alcohol Abuse 41:2, pages 153-160.
Read now
Elizabeth Ralevski, Lening A Olivera-Figueroa & Ismene Petrakis. (2014) PTSD and comorbid AUD: a review of pharmacological and alternative treatment options. Substance Abuse and Rehabilitation 5, pages 25-36.
Read now
Clifford M. Knapp, Matthew O’Malley, Subimal Datta & Domenic A. Ciraulo. (2014) The Kv7 potassium channel activator retigabine decreases alcohol consumption in rats. The American Journal of Drug and Alcohol Abuse 40:3, pages 244-250.
Read now
Clifford M. Knapp, Ofra Sarid-Segal, Mark A. Richardson, Laurie Sickles Colaneri, Maryam Afshar, Eric Devine, Chris C. Streeter, Joanne Piechniczek-Buczek & Domenic A. Ciraulo. (2010) Open Label Trial of the Tolerability and Efficacy of Zonisamide in the Treatment of Alcohol Dependence. The American Journal of Drug and Alcohol Abuse 36:2, pages 102-105.
Read now

Articles from other publishers (19)

Henry R. Kranzler & Emily E. Hartwell. (2023) Medications for treating alcohol use disorder: A narrative review. Alcohol: Clinical and Experimental Research 47:7, pages 1224-1237.
Crossref
Fahad S. Alshehri. (2023) A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov. Medicina 59:6, pages 1101.
Crossref
András H. Lékó, Mehdi Farokhnia & Lorenzo Leggio. 2023. Alcohol and Alcohol-related Diseases. Alcohol and Alcohol-related Diseases 261 288 .
Muhammad Sona Khan, Wulfran Trenet, Nancy Xing, Britta Sibley, Muzaffar Abbas, Mariya al-Rashida, Khalid Rauf & Chitra D. Mandyam. (2020) A Novel Sulfonamide, 4-FS, Reduces Ethanol Drinking and Physical Withdrawal Associated With Ethanol Dependence. International Journal of Molecular Sciences 21:12, pages 4411.
Crossref
Jasmine Turna, Sabrina K. Syan, Benicio N. Frey, Brian Rush, Mary Jean Costello, Mark Weiss & James MacKillop. (2019) Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review. Alcoholism: Clinical and Experimental Research 43:4, pages 550-563.
Crossref
Lara A. Ray, Emily Hartwell, ReJoyce Green & Alexandra Venegas. 2019. The Assessment and Treatment of Addiction. The Assessment and Treatment of Addiction 123 135 .
Chidera C. Chukwueke & Bernard Le Foll. 2019. Psychiatric Disorders. Psychiatric Disorders 195 219 .
Lorenzo Leggio, Daniel E. Falk, Megan L. Ryan, Joanne Fertig & Raye Z. Litten. 2020. Substance Use Disorders. Substance Use Disorders 443 462 .
Megan M. Yardley & Lara A. Ray. (2017) Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addiction Biology 22:3, pages 581-615.
Crossref
Agata Krupa-Burtnik, Ewa Zwierzyńska, Anna Kordala & Bogusława Pietrzak. (2017) The Impact of Zonisamide on the Development and Course of Alcohol Dependence in Rabbits. A pharmaco-EEG study. Alcohol and Alcoholism 52:3, pages 282-288.
Crossref
Raye Z. Litten, Daniel E. Falk, Megan L. Ryan, Joanne Fertig & Lorenzo Leggio. 2018. The Neuropharmacology of Alcohol. The Neuropharmacology of Alcohol 579 613 .
Christopher J. Hammond, Mark J. Niciu, Shannon Drew & Albert J. Arias. (2015) Anticonvulsants for the Treatment of Alcohol Withdrawal Syndrome and Alcohol Use Disorders. CNS Drugs 29:4, pages 293-311.
Crossref
Clifford M. Knapp, Domenic A. Ciraulo, Ofra Sarid-Segal, Mark A. Richardson, Eric Devine, Chris C. Streeter, Marlene Oscar-Berman, Caitlin Surprise, Laurie Colaneri, Meghan Putnam, Megan Waters & Courtney Richambault. (2015) Zonisamide, Topiramate, and Levetiracetam. Journal of Clinical Psychopharmacology 35:1, pages 34-42.
Crossref
Bogusława Pietrzak, Ewa Zwierzyńska & Agata Krupa. (2014) A Pharmaco-EEG-Based Assessment of the Interaction Between Ethanol and Zonisamide. Alcohol and Alcoholism 49:5, pages 505-514.
Crossref
Domenic A. Ciraulo & Mark Oldham. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System 499 532 .
Martin H. Plawecki, Leah Wetherill, Victor Vitvitskiy, Ann Kosobud, Ulrich S. Zimmermann, Howard J. Edenberg & Sean O'Connor. (2013) Voluntary Intravenous Self-Administration of Alcohol Detects an Interaction Between GABAergic Manipulation and GABRG1 Polymorphism Genotype: A Pilot Study . Alcoholism: Clinical and Experimental Research 37, pages E152-E160.
Crossref
Adam J. Schwarz, Martin H. Plawecki, David L. McKinzie & Conrad J. Wong. 2013. Translational Neuroimaging. Translational Neuroimaging 307 341 .
Gabriel Rubio, Francisco López-Muñoz, Francisco Ferre, Isabel Martínez-Gras, Guillermo Ponce, José M. Pascual, Miguel A. Jiménez-Arriero & Cecilio Alamo. (2010) Effects of Zonisamide in the Treatment of Alcohol Dependence. Clinical Neuropharmacology 33:5, pages 250-253.
Crossref
Albert J. Arias, Richard Feinn, Cheryl Oncken, Jonathan Covault & Henry R. Kranzler. (2010) Placebo-Controlled Trial of Zonisamide for the Treatment of Alcohol Dependence. Journal of Clinical Psychopharmacology 30:3, pages 318-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.